Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,953 results for ""Angiotensin II Type 1 Receptor Blockers""

Your Filters

Subject : hypertension
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Age-Related Effects of AT1 Receptor Antagonist Losartan on Cognitive Decline in Spontaneously Hypertensive Rats.

  • Authors : Tchekalarova J; Department of Behavioral Neurobiology, Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.; Department of Organic Chemistry, University of Chemical Technology and Metallurgy, 1756 Sofia, Bulgaria.

Subjects: Losartan*/Losartan*/Losartan*/pharmacology ; Losartan*/Losartan*/Losartan*/therapeutic use ; Rats, Inbred SHR*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 04; Vol. 25 (13). Date of Electronic Publication: 2024 Jul 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries.

  • Authors : Gadanec LK; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.; Swiderski J

Subjects: Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/therapeutic use ; Hypertension*/Hypertension*/Hypertension*/drug therapy; Rabbits

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 16; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Safety, tolerability, and outcomes of losartan use in patients hospitalized with SARS-CoV-2 infection: A feasibility study.

  • Authors : Bolotova O; Department of Medicine, Stony Brook University, Stony Brook, NY, United States of America.; Yoo J

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; COVID-19/COVID-19/COVID-19/*pathology ; Hypertension/Hypertension/Hypertension/*drug therapy

  • Source: PloS one [PLoS One] 2020 Dec 30; Vol. 15 (12), pp. e0244708. Date of Electronic Publication: 2020 Dec 30 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Angiotensin receptor blockade with Losartan attenuates pressor response to handgrip contraction and enhances natriuresis in salt loaded hypertensive subjects: a quasi-experimental study among Nigerian adults.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*administration & dosage ; Hypertension/Hypertension/Hypertension/*drug therapy ; Losartan/Losartan/Losartan/*administration & dosage

  • Source: The Pan African medical journal [Pan Afr Med J] 2019 Dec 09; Vol. 34, pp. 188. Date of Electronic Publication: 2019 Dec 09 (Print Publication: 2019).Publisher: African Field Epidemiology Network Country of Publication: Uganda NLM ID: 101517926 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Chemometric and Design of Experiments-Based Analytical Quality by Design and Green Chemistry Approaches to Multipurpose High-Pressure Liquid Chromatographic Method for Synchronous Estimation of Multiple Fixed-Dose Combinations of Azilsartan Medoxomil.

  • Authors : Prajapati P; Department of Quality Assurance, Maliba Pharmacy College, Maliba Campus, Bardoli-Mahuva Road, Tarsadi, Mahuva, Surat, Gujarat 394 350, India.; Shahi A

Subjects: Chemometrics* ; Hypertension*/Hypertension*/Hypertension*/drug therapy; Humans

  • Source: Journal of AOAC International [J AOAC Int] 2022 Dec 22; Vol. 106 (1), pp. 250-260.Publisher: Oxford University Press Country of Publication: England NLM ID: 9215446 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan.

  • Authors : Omboni S; Clinical Research Unit, Italian Institute of Telemedicine, Varese, Italy.; Scientific Research Department of Cardiology, Science and Technology Park for Biomedicine, Sechenov First Moscow State Medical University, Moscow, Russian Federation.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Arterial Pressure/Arterial Pressure/Arterial Pressure/*drug effects

  • Source: Cardiovascular therapeutics [Cardiovasc Ther] 2018 Dec; Vol. 36 (6), pp. e12471. Date of Electronic Publication: 2018 Nov 13.Publisher: Hindawi Country of Publication: England NLM ID: 101319630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-5922

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Upstream therapeutic strategies of valsartan and fluvastatin on hypertensive patients with non-permanent atrial fibrillation.

  • Authors : Zhao Z; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.; Niu X

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Anti-Arrhythmia Agents/Anti-Arrhythmia Agents/Anti-Arrhythmia Agents/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use

  • Source: Cardiovascular therapeutics [Cardiovasc Ther] 2018 Dec; Vol. 36 (6), pp. e12478. Date of Electronic Publication: 2018 Nov 28.Publisher: Hindawi Country of Publication: England NLM ID: 101319630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-5922

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension.

  • Authors : Hjermitslev M; Department of Biomedicine, Pharmacology, Aarhus University, Aarhus C, Denmark.; Grimm DG

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2017 Oct; Vol. 121 (4), pp. 225-233. Date of Electronic Publication: 2017 Jun 19.Publisher: Blackwell Country of Publication: England NLM ID: 101208422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-7843

Record details

Read Online Read More Add to Saved list
×
Academic Journal

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.

  • Authors : Jo SH; Division of Cardiology, Hallym University Sacred Heart Hospital/Hallym University College of Medicine, 896, Pyeongchon-dong, Dongan-gu, Anyang-si, Gyeonggi-do, 431-070, South Korea.; Park SJ

Subjects: Amlodipine/Amlodipine/Amlodipine/*therapeutic use ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use

  • Source: Trials [Trials] 2018 Jun 20; Vol. 19 (1), pp. 324. Date of Electronic Publication: 2018 Jun 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Antihypertensive efficacy and safety of the angiotensin receptor blocker azilsartan in elderly patients with hypertension.

  • Authors : Kamada T; a Department of Cardiology , Fujita Health University, Banbuntane Hotokukai Hospital , Nagoya , Japan and.; b Department of Cardiology , Fujita Health University , Toyoake , Japan.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: Drug and chemical toxicology [Drug Chem Toxicol] 2017 Jan; Vol. 40 (1), pp. 110-114. Date of Electronic Publication: 2016 Jul 17.Publisher: Taylor & Francis Group Country of Publication: United States NLM ID: 7801723 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  1,953 results for ""Angiotensin II Type 1 Receptor Blockers""